mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer

Pancreatic cancer is one of the highly malignant cancers that have poor prognosis and limited treatment options. The development of targeted therapies is important for improving patient outcomes. In this study, we analyzed the datasets from the GEO database to identify potential mRNA biomarkers for...

Full description

Saved in:
Bibliographic Details
Main Authors: Saima Firdaus, Rafat Parveen
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Biology and Life Sciences Forum
Subjects:
Online Access:https://www.mdpi.com/2673-9976/43/1/2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850156051886768128
author Saima Firdaus
Rafat Parveen
author_facet Saima Firdaus
Rafat Parveen
author_sort Saima Firdaus
collection DOAJ
description Pancreatic cancer is one of the highly malignant cancers that have poor prognosis and limited treatment options. The development of targeted therapies is important for improving patient outcomes. In this study, we analyzed the datasets from the GEO database to identify potential mRNA biomarkers for pancreatic cancer. Differentially expressed gene (DEG) analysis was performed in R to identify genes that expressed differentially between tumor and normal samples. TFF1 and LAMC2 emerged as key candidate genes for pancreatic cancer among the identified DEGs. Additionally drugs approved by the FDA were repurposed as an inhibitor against key genes. These findings suggest that these genes play a significant role in pancreatic cancer progression and have the potential to serve as molecular elements for targeted therapies.
format Article
id doaj-art-c6462c8e36f5497e89eaacbbe99e2e3f
institution OA Journals
issn 2673-9976
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Biology and Life Sciences Forum
spelling doaj-art-c6462c8e36f5497e89eaacbbe99e2e3f2025-08-20T02:24:42ZengMDPI AGBiology and Life Sciences Forum2673-99762025-03-01431210.3390/blsf2025043002mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic CancerSaima Firdaus0Rafat Parveen1Department of Computer Science, Jamia Millia Islamia, New Delhi 110025, IndiaDepartment of Computer Science, Jamia Millia Islamia, New Delhi 110025, IndiaPancreatic cancer is one of the highly malignant cancers that have poor prognosis and limited treatment options. The development of targeted therapies is important for improving patient outcomes. In this study, we analyzed the datasets from the GEO database to identify potential mRNA biomarkers for pancreatic cancer. Differentially expressed gene (DEG) analysis was performed in R to identify genes that expressed differentially between tumor and normal samples. TFF1 and LAMC2 emerged as key candidate genes for pancreatic cancer among the identified DEGs. Additionally drugs approved by the FDA were repurposed as an inhibitor against key genes. These findings suggest that these genes play a significant role in pancreatic cancer progression and have the potential to serve as molecular elements for targeted therapies.https://www.mdpi.com/2673-9976/43/1/2pancreatic cancerbiomarkermRNA-based biomarkertarget therapypersonalized treatment
spellingShingle Saima Firdaus
Rafat Parveen
mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
Biology and Life Sciences Forum
pancreatic cancer
biomarker
mRNA-based biomarker
target therapy
personalized treatment
title mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
title_full mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
title_fullStr mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
title_full_unstemmed mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
title_short mRNA-Based Biomarker Identification for Targeted Therapy Development in Pancreatic Cancer
title_sort mrna based biomarker identification for targeted therapy development in pancreatic cancer
topic pancreatic cancer
biomarker
mRNA-based biomarker
target therapy
personalized treatment
url https://www.mdpi.com/2673-9976/43/1/2
work_keys_str_mv AT saimafirdaus mrnabasedbiomarkeridentificationfortargetedtherapydevelopmentinpancreaticcancer
AT rafatparveen mrnabasedbiomarkeridentificationfortargetedtherapydevelopmentinpancreaticcancer